• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

胰岛素分泌功能障碍与胰岛素抵抗在韩国2型糖尿病发病机制中的作用

Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus.

作者信息

Kim D J, Lee M S, Kim K W, Lee M K

机构信息

Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

出版信息

Metabolism. 2001 May;50(5):590-3. doi: 10.1053/meta.2001.22558.

DOI:10.1053/meta.2001.22558
PMID:11319722
Abstract

Although insulin resistance has been shown to be a primary defect causing type 2 (non insulin-dependent) diabetes mellitus in Pima Indians and Caucasians, insulin secretory defect has also been known to be an important factor in the development of type 2 diabetes. We undertook a study to investigate the initial abnormality of glucose intolerance in Koreans. A total of 370 Korean subjects were classified into 5 groups according to their degree of glucose intolerance (normal fasting glucose [NFG]/normal glucose tolerance [NGT], n = 95; impaired fasting glucose [IFG]/NGT, n = 29; NFG/impaired glucose tolerance [IGT], n = 60; IFG/IGT, n = 68; diabetes, n = 118). Insulinogenic index was used as an index of early-phase insulin secretion. Insulin resistance was assessed by the R value of the homeostasis model assessment [HOMA(R)]. Insulinogenic index significantly decreased in subjects with IFG/NGT and NFG/IGT compared with those with NFG/NGT. However, there was no significant difference in HOMA(R) between subjects with NFG/NGT and those with IFG/NGT or NFG/IGT. Insulinogenic index decreased significantly with the increase of plasma glucose 120-minute value at the earlier stage of glucose intolerance compared with HOMA(R). These results suggest that early-phase insulin secretory defect may be the initial abnormality in the development of type 2 diabetes in Korean subjects.

摘要

尽管胰岛素抵抗已被证明是导致皮马印第安人和高加索人患2型(非胰岛素依赖型)糖尿病的主要缺陷,但胰岛素分泌缺陷也是2型糖尿病发病的一个重要因素。我们进行了一项研究,以调查韩国人葡萄糖耐量异常的初始情况。根据葡萄糖耐量程度,将370名韩国受试者分为5组(空腹血糖正常[NFG]/葡萄糖耐量正常[NGT],n = 95;空腹血糖受损[IFG]/NGT,n = 29;NFG/葡萄糖耐量受损[IGT],n = 60;IFG/IGT,n = 68;糖尿病,n = 118)。胰岛素生成指数用作早期胰岛素分泌的指标。通过稳态模型评估的R值[HOMA(R)]评估胰岛素抵抗。与NFG/NGT组相比,IFG/NGT组和NFG/IGT组受试者的胰岛素生成指数显著降低。然而,NFG/NGT组与IFG/NGT组或NFG/IGT组受试者之间的HOMA(R)无显著差异。与HOMA(R)相比,在葡萄糖耐量异常早期,随着血浆葡萄糖120分钟值的升高,胰岛素生成指数显著降低。这些结果表明,早期胰岛素分泌缺陷可能是韩国受试者2型糖尿病发病的初始异常情况。

相似文献

1
Insulin secretory dysfunction and insulin resistance in the pathogenesis of korean type 2 diabetes mellitus.胰岛素分泌功能障碍与胰岛素抵抗在韩国2型糖尿病发病机制中的作用
Metabolism. 2001 May;50(5):590-3. doi: 10.1053/meta.2001.22558.
2
Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.日本受试者中空腹血糖受损和糖耐量受损之间胰岛素作用与分泌、血浆脂质及血压水平的差异。
Hypertens Res. 2008 Jul;31(7):1357-63. doi: 10.1291/hypres.31.1357.
3
Pathogenesis of pre-diabetes: mechanisms of fasting and postprandial hyperglycemia in people with impaired fasting glucose and/or impaired glucose tolerance.糖尿病前期的发病机制:空腹血糖受损和/或糖耐量受损人群空腹及餐后高血糖的机制
Diabetes. 2006 Dec;55(12):3536-49. doi: 10.2337/db06-0319.
4
Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.空腹血糖受损和/或糖耐量受损个体的代谢特征。
Diabetes. 1999 Nov;48(11):2197-203. doi: 10.2337/diabetes.48.11.2197.
5
Insulin sensitivity and secretion in Arab Americans with glucose intolerance.阿拉伯裔美国人糖耐量异常者的胰岛素敏感性和分泌功能。
Diabetes Technol Ther. 2013 Dec;15(12):1019-24. doi: 10.1089/dia.2013.0045. Epub 2013 Aug 6.
6
Pathophysiologic heterogeneity in the development of type 2 diabetes mellitus in Korean subjects.韩国人群2型糖尿病发生过程中的病理生理异质性。
Diabetes Res Clin Pract. 2005 Aug;69(2):180-7. doi: 10.1016/j.diabres.2004.12.011.
7
Different mechanisms for impaired fasting glucose and impaired postprandial glucose tolerance in humans.人类空腹血糖受损和餐后糖耐量受损的不同机制。
Diabetes Care. 2006 Aug;29(8):1909-14. doi: 10.2337/dc06-0438.
8
Glucose tolerance, insulin secretion, and insulin sensitivity in nonobese and obese Japanese subjects.非肥胖和肥胖日本受试者的葡萄糖耐量、胰岛素分泌及胰岛素敏感性
Diabetes Care. 1997 Oct;20(10):1562-8. doi: 10.2337/diacare.20.10.1562.
9
Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.葡萄糖耐量中间反应异常者未来患糖尿病的风险与糖耐量受损者一样高。
J Assoc Physicians India. 2007 Dec;55:833-7.
10
Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.根据世界卫生组织和美国糖尿病协会诊断标准对韩国人群糖耐量类别进行的比较。
Korean J Intern Med. 2000 Jan;15(1):37-41. doi: 10.3904/kjim.2000.15.1.37.

引用本文的文献

1
Ketone Body Induction: Insights into Metabolic Disease Management.酮体诱导:对代谢性疾病管理的见解。
Biomedicines. 2025 Jun 16;13(6):1484. doi: 10.3390/biomedicines13061484.
2
Young-onset type 2 diabetes-Epidemiology, pathophysiology, and management.青年发病型2型糖尿病——流行病学、病理生理学及管理
J Diabetes Investig. 2025 Jul;16(7):1157-1172. doi: 10.1111/jdi.70081. Epub 2025 May 24.
3
Conundrum and chances of diabetes management in the Western Pacific Region: A narrative review.西太平洋地区糖尿病管理的难题与机遇:一篇叙述性综述
J Diabetes Investig. 2025 Aug;16(8):1357-1366. doi: 10.1111/jdi.70053. Epub 2025 May 15.
4
Evolving Characteristics of Type 2 Diabetes Mellitus in East Asia.东亚2型糖尿病的演变特征
Endocrinol Metab (Seoul). 2025 Feb;40(1):57-63. doi: 10.3803/EnM.2024.2193. Epub 2025 Jan 15.
5
Effects of insulin resistance and β-cell function on diabetic complications in Korean diabetic patients.胰岛素抵抗和β细胞功能对韩国糖尿病患者糖尿病并发症的影响。
PLoS One. 2024 Oct 22;19(10):e0312439. doi: 10.1371/journal.pone.0312439. eCollection 2024.
6
Comparison of METS-IR and HOMA-IR for predicting new-onset CKD in middle-aged and older adults.METS-IR与HOMA-IR在预测中老年人群新发慢性肾脏病方面的比较。
Diabetol Metab Syndr. 2023 Nov 14;15(1):230. doi: 10.1186/s13098-023-01214-7.
7
Evaluation of hormonal and circulating inflammatory biomarker profiles in the year following bariatric surgery.减重手术后一年内激素及循环炎症生物标志物谱的评估。
Front Endocrinol (Lausanne). 2023 Jul 25;14:1171675. doi: 10.3389/fendo.2023.1171675. eCollection 2023.
8
Resting energy expenditure in Korean type 2 diabetes patients: comparison between measured and predicted values.韩国2型糖尿病患者的静息能量消耗:实测值与预测值的比较。
Nutr Res Pract. 2023 Jun;17(3):464-474. doi: 10.4162/nrp.2023.17.3.464. Epub 2022 Oct 19.
9
The Prevalence and Characteristics of Exocrine Pancreatic Insufficiency in Patients with Type 2 Diabetes: A Systematic Review and Meta-Analysis.2型糖尿病患者外分泌性胰腺功能不全的患病率及特征:一项系统评价和荟萃分析
Int J Endocrinol. 2022 Jul 19;2022:7764963. doi: 10.1155/2022/7764963. eCollection 2022.
10
Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61).基于日本 2 型糖尿病患者体重指数的口服抗糖尿病药物处方模式的现状及 2002 年至 2019 年期间糖尿病专家处方模式的年度变化(JDDM61)。
J Diabetes Investig. 2022 Jan;13(1):65-73. doi: 10.1111/jdi.13621. Epub 2021 Jul 30.